Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02929576 |
| Title | Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer (ENDEAR) |
| Acronym | ENDEAR |
| Recruitment | Withdrawn |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Medivation, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Topeka | Kansas | 66606 | United States | Details | ||
| Metairie | Louisiana | 70006 | United States | Details | ||
| Bronx | New York | 10469 | United States | Details | ||
| Houston | Texas | 77030 | United States | Details | ||
| Tacoma | Washington | 98405 | United States | Details | ||
| Wenatchee | Washington | 98801 | United States | Details |